Our univariate analysis of 81 NB cases identified a high level of STMN1 expression as a significant prognostic factor associated with poor survival (hazard ratio = 6.439, 95% CI = 1.882–22.03, p = 0.003). This evidence concerns the gene STMN1 and neuroblastoma.